These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6411893)

  • 21. Pre-systemic metabolism of viprostol in the monkey following oral and topical administration.
    Nicolau G; Tonelli AP; Cosulich DB; Perkinson NA; DiCioccio AT; McWilliams WE; Yacobi A
    Xenobiotica; 1988 Jul; 18(7):797-802. PubMed ID: 3176518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey.
    Adams WJ; McGovren JP; Dalm EA; Brewer JE; Hosley JD
    Cancer Res; 1989 Nov; 49(22):6328-36. PubMed ID: 2529962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacokinetics of lisuride hydrogen maleate in rat, rabbit and rhesus monkey.
    Humpel M; Toda T; Oshino N; Pommerenke G
    Eur J Drug Metab Pharmacokinet; 1981; 6(3):207-19. PubMed ID: 7308240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of mepindolol sulfate in the rat, dog, and rhesus monkey. Studies on species differences.
    Krause W; Kühne G
    Drug Metab Dispos; 1983; 11(2):91-6. PubMed ID: 6133729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of coumarin and 7-hydroxycoumarin in the rhesus monkey after intravenous and peroral administration.
    Ritschel WA; Denson DD; Grummich KW
    Arzneimittelforschung; 1988 Nov; 38(11):1619-23. PubMed ID: 3214445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys.
    Mattiuz E; Franklin R; Gillespie T; Murphy A; Bernstein J; Chiu A; Hotten T; Kassahun K
    Drug Metab Dispos; 1997 May; 25(5):573-83. PubMed ID: 9152596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of human leptin in mice and rhesus monkeys.
    Ahrén B; Baldwin RM; Havel PJ
    Int J Obes Relat Metab Disord; 2000 Dec; 24(12):1579-85. PubMed ID: 11126209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of the bioavailability of nitroglycerin from a transdermal therapeutic system (Nitroderm TTS).
    Imhof PR; Vuillemin T; Gérardin A; Racine A; Müller P; Follath F
    Eur J Clin Pharmacol; 1984; 27(1):7-12. PubMed ID: 6436032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disposition of nitroglycerin in the beagle dog after intravenous and buccal administration.
    Ritschel WA; Shaaya AN; Tan HS
    Methods Find Exp Clin Pharmacol; 1985 Jun; 7(6):307-13. PubMed ID: 3932795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous absorption and excretion of alachlor in rhesus monkeys.
    Kronenberg JM; Fuhremann TW; Johnson DE
    Fundam Appl Toxicol; 1988 May; 10(4):664-71. PubMed ID: 3396793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic disposition of guanabenz in the rhesus monkey.
    Meacham RH; Chiang ST; Kick CJ; Sisenwine SF; Jusko WJ; Ruelius HW
    Drug Metab Dispos; 1981; 9(6):509-14. PubMed ID: 6120807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous absorption of pentachlorophenol from soil.
    Wester RC; Maibach HI; Sedik L; Melendres J; Wade M; DiZio S
    Fundam Appl Toxicol; 1993 Jan; 20(1):68-71. PubMed ID: 8432428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys.
    Colletti AE; Krieter PA
    Drug Metab Dispos; 1994; 22(2):183-8. PubMed ID: 8013272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rectal absorption of nitroglycerin in the rat: avoidance of first-pass metabolism as a function of rectal length exposure.
    Kamiya A; Ogata H; Fung HL
    J Pharm Sci; 1982 Jun; 71(6):621-4. PubMed ID: 6808113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous metabolism of nitroglycerin in vitro. I. Homogenized versus intact skin.
    Higo N; Hinz RS; Lau DT; Benet LZ; Guy RH
    Pharm Res; 1992 Feb; 9(2):187-90. PubMed ID: 1553339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of dose and ointment application technique on nitroglycerin plasma concentrations.
    Iafrate RP; Yost RL; Curry SH; Gotz VP; Caranasos GJ
    Pharmacotherapy; 1983; 3(2 Pt 1):118-24. PubMed ID: 6406987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid. 5th communication: factors affecting percutaneous absorption in rats.
    Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Okamura Y; Kashiwazaki K; Takahashi N
    Arzneimittelforschung; 1997 Mar; 47(3):270-5. PubMed ID: 9105545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Site dependence for topical absorption of nitroglycerin in rats.
    Horhota ST; Fung HL
    J Pharm Sci; 1978 Sep; 67(9):1345-6. PubMed ID: 99511
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.